Association of Parathyroid Hormone with Markers of Bone-Mineral Metabolism in Patients of Chronic Kidney Disease with Secondary Hyperparathyroidism

Journal Title: International Journal of Medical Research Professionals - Year 2017, Vol 3, Issue 6

Abstract

Background: Secondary hyperparathyroidism (SHPT) is one of the most obvious complications of chronic kidney disease (CKD). The pathogenesis of SHPT is complex and dependent on the imbalance of various biochemical markers of bone and mineral metabolism. Aim: The present study was planned to evaluate the association of intact Parathyroid Hormone (iPTH) levels in CKD patients with bone-mineral metabolism markers. Materials & Methods: Fifty diagnosed cases of CKD (stage 4 & 5), age up to 60 years were enrolled for the study. Fifty age and sex matched healthy individuals constituted the control group. Blood samples were collected using standard aseptic technique and subjected to analysis for serum Urea, Creatinine, uric acid, Calcium, Phosphorus, Alkaline phosphatase, 25(OH) Vitamin D and intact parathyroid hormone. Estimated Glomorular Filtration Rate was calculated by applying Cockeroft and Gault formula. Results obtained were compared between CKD patients and control group statistically by applying students’ t-test. Pearson correlation for iPTH and other parameters were also evaluated. Results: Besides deranged renal function, CKD patients exhibited hypovitaminosis D and hyperparathyroidism. The study also reported low levels of S Ca++, while S phosphorus and ALKP were significantly higher. iPTH demonstrated a significant negative correlation with S Ca++ (r = -0.418). A significant correlation was also observed between iPTH and S phosphorus(r =0.554) and ALKP (r=0.291). Conclusion: Hyperparathyroidism is a common complication of end stage renal disease (ESRD). iPTH demonstrates strong association with S. Ca++, Phosphorus and ALKP, which are directly responsible for homeostasis of bone-mineral metabolism, in CKD patients. Monitoring of these markers in CKD patients shall be helpful in better management and in diminishing the occurrence of various comorbid conditions

Authors and Affiliations

Bushra Fiza, Jai Prakash, Suraj Godara, Maheep Sinha

Keywords

Related Articles

Evaluation on Effects of Saroglitazar on HbA1c and Triglycerides on Patients with Type 2 Diabetes Mellitus: An Observational Study

Saroglitazar has demonstrated significant reduction in triglycerides (TG) along with favorable effect on glycemic indices in diabetic patients. Our aim was to be the effects of saroglitazar on HbA1c and also on Triglycer...

Long Term Consumption of High Dose Sucralose Induces Hepatic Necrosis and Fibrosis in Male Albino Rats

Background: Sucralose is one of the most popular non-nutritive sweeteners in the market. Whoever its toxicological effect are still need further investigation Materials and Methods: Three groups of 50 rats formed of a co...

A Study of Psychiatric Comorbidity in Alcohol Dependent Patients in North-West Rajasthan

Background: Comorbidity indicated the presence of a individual clinical existence that has survive or may occur during the clinical course of a patient having the index disease. Though alcohol is one of the usually drugs...

Assessment of Knowledge about HIV Disease (AIDS) Among Pregnant Women in Tabuk City

Introduction: Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV). Following initial infec...

Comparison Between Intravaginal Misoprostol (PGE1) and Dinoprostone (PGE2) in Induction of Labour

Introduction: Induction of labour is needed in many patients to improve outcomes of pregnancy. It is important to identify the most suitable agent to assist the progression of natural labour. Aims & Objectives: To conduc...

Download PDF file
  • EP ID EP548391
  • DOI 10.21276/ijmrp.2017.3.6.009
  • Views 47
  • Downloads 0

How To Cite

Bushra Fiza, Jai Prakash, Suraj Godara, Maheep Sinha (2017). Association of Parathyroid Hormone with Markers of Bone-Mineral Metabolism in Patients of Chronic Kidney Disease with Secondary Hyperparathyroidism. International Journal of Medical Research Professionals, 3(6), 44-49. https://europub.co.uk/articles/-A-548391